Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WIFI: Antibiotic Prophylaxis for Implant Removal
NCT02225821Phase 4Completed
- Sponsor
- University of Amsterdam
- Start
- Nov 2014
- Primary completion
- Nov 2016
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 4 trial of cefazolin in surgical site infection (SSI), sponsored by University of Amsterdam. Started Nov 2014; status: completed.
02
Drugs
cefazolin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT02225821.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02225821.